The animal world is full of species that can perform astonishing, and sometimes disgusting, feats. Take vultures, for example. “They eat this rotten meat that is full of pathogens and toxins, and they stay healthy,” Neta Raab told BioWorld. Raab is the co-founder and CEO of Wild Biotech Ltd., an Israeli startup that is seeking to understand gut microbiome contributions to these animal superpowers, and harness them for therapeutic use.
A Chinese study has shown that small extracellular vesicles produced by microRNA-overexpressing mesenchymal stem cells improved cardiac function, reduced infarct size and promoted angiogenesis without arrhythmia in nonhuman primate models of myocardial infarction.
Keeping you up to date on recent developments in orthopedics, including: TKR a cost-effective treatment for patients with knee osteoarthritis; Nonsurgical treatment quickly reduces arthritis knee pain and improves function; Inflammation and pressure-sensing leads to 'feed-forward' loop in osteoarthritis.
A study by Korean and U.S. geneticists has demonstrated that the newly developed Gene set analysis Association Using Sparse Signals (GAUSS) is more powerful than existing methods for detecting phenotype-associated gene sets and facilitating interpretation of gene set analysis results.
LONDON – The alchemy of induced pluripotent cells has broken another barrier, delivering a model of the earliest preimplantation stages of human development, when fertilized eggs form a blastocyst.
Keeping you up to date on recent developments in oncology, including: New technique may enable electrons in cancer radiotherapy; Universal initiates study of cell-free DNA blood test; Concerns linger about cardiovascular risk factors in conjunction with cancer treatment.
Vaccines now in clinical trials can raise broad-spectrum antibodies against more than one form of hemagglutinin and provide protection against the flu strains that have been most troublesome from a public health perspective.
Keeping you up to date on recent developments in cardiology, including: Translational medicine slow to change cardiovascular care; New study results boost case for BASILICA; Mitral repair still worthwhile despite issues with atrial fibrillation.